Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × brivanib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1 Gastrointestinal 1

Conditions

Sarcoma 1 Endometrial Adenocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 3 Nivolumab 2 obinutuzumab 1 naptumomab estafenatox 1 durvalumab 1 brivanib 1 abemaciclib 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00633789 2015-10-09

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Bristol-Myers Squibb

Phase 2 Completed

GastrointestinalGenitourinarySarcoma

Adenocarcinoma Of Esophagus, Carcinoma, Transitional Cell, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡